Syros Pharmaceuticals Inc.. (SYRS) NASDAQ
$5.35 (0.49) (-8.39%)
Market Cap: $33.71M
As of 03/28/24 04:00 PM EDT. Market closed.
Syros Pharmaceuticals Inc.. (SYRS)
NASDAQ
$5.35
(0.49) (-8.39%)
Market Cap: $33.71M
As of 03/28/24 04:00 PM EDT. Market closed.
syros pharmaceuticals is a life sciences company that is focused on treating disease by mapping gene regulatory circuits and modulating the factors that regulate gene expression. syros has pioneered world-leading gene control research and drug discovery capabilities with a proven ability to integrate disease biology and genomic data--a proficiency that is not well represented in pharmaceutical ... read more
syros pharmaceuticals is a life sciences company that is focused on treating disease by mapping gene regulatory circuits and modulating the factors that regulate gene expression. syros has pioneered world-leading gene control research and drug discovery capabilities with a proven ability to integrate disease biology and genomic data--a proficiency that is not well represented in pharmaceutical r&d. central to the syros approach is a proprietary platform of carefully integrated assay technologies, bioinformatics, and biologic insights developed by members of syros' senior leadership. while this scientific approach has applications in many therapeutic areas, syros has demonstrated success initially in oncology, where it may help address numerous unmet medical needs. read less
Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
AKKARAJU SRINIVAS | Director | Dec 21, 2023 | Buy | $4.42 | 904,977 | 3,999,998 | 1,786,427 | Dec 26, 2023, 05:24 PM |
Roth David | Chief Medical Officer | Dec 12, 2023 | Sale | $4.95 | 6,287 | 31,121 | 0 | Dec 14, 2023, 04:24 PM |
Roth David | Chief Medical Officer | Dec 06, 2023 | Sale | $3.95 | 6,287 | 24,834 | 6,287 | Dec 08, 2023, 04:23 PM |
Simonian Nancy A | President & CEO | Nov 01, 2023 | Option Exercise | $2.22 | 13,401 | 29,750 | 100,144 | Nov 02, 2023, 04:54 PM |
Haas Jason | Chief Financial Officer | Nov 01, 2023 | Option Exercise | $2.22 | 6,301 | 13,988 | 13,951 | Nov 02, 2023, 04:53 PM |
Roth David | Chief Medical Officer | Nov 01, 2023 | Option Exercise | $2.22 | 6,301 | 13,988 | 12,574 | Nov 02, 2023, 04:52 PM |
Stephens Kristin | Chief Development Officer | Nov 01, 2023 | Option Exercise | $2.22 | 5,676 | 12,601 | 15,789 | Nov 02, 2023, 04:52 PM |
Chee Conley | Chief Commercial Officer | Nov 01, 2023 | Option Exercise | $2.22 | 6,004 | 13,329 | 12,338 | Nov 02, 2023, 04:51 PM |
Quirk Gerald E | Chief Legal & Compliance Offic | Oct 19, 2023 | Option Exercise | $2.10 | 6,897 | 14,484 | 24,303 | Oct 20, 2023, 04:23 PM |
Roth David | Chief Medical Officer | Jul 31, 2023 | Sale | $3.95 | 7,348 | 29,025 | 0 | Aug 02, 2023, 04:21 PM |
Olson Eric R | Chief Scientific Officer | Jul 17, 2023 | Sale | $3.50 | 689 | 2,412 | 6,661 | Jul 18, 2023, 08:27 PM |
Haas Jason | Chief Financial Officer | Apr 03, 2023 | Option Exercise | $2.58 | 623 | 1,607 | 1,377 | Apr 04, 2023, 06:57 PM |
Chee Conley | Chief Commercial Officer | Apr 03, 2023 | Option Exercise | $2.58 | 658 | 1,698 | 1,342 | Apr 04, 2023, 06:56 PM |
Roth David | Chief Medical Officer | Apr 03, 2023 | Option Exercise | $2.58 | 623 | 1,607 | 7,348 | Apr 04, 2023, 06:56 PM |
Stephens Kristin | Chief Development Officer | Apr 03, 2023 | Option Exercise | $2.58 | 623 | 1,607 | 4,465 | Apr 04, 2023, 06:55 PM |
Olson Eric R | Chief Scientific Officer | Apr 03, 2023 | Option Exercise | $2.58 | 623 | 1,607 | 7,350 | Apr 04, 2023, 06:54 PM |
Simonian Nancy A | President & CEO | Apr 03, 2023 | Option Exercise | $2.58 | 1,852 | 4,778 | 73,420 | Apr 04, 2023, 06:54 PM |
TYSON TIMOTHY | Director | Sep 30, 2022 | Buy | $6.37 | 14,000 | 89,186 | 24,932 | Oct 03, 2022, 04:42 PM |
TYSON TIMOTHY | Director | Sep 29, 2022 | Buy | $5.72 | 2,932 | 16,770 | 10,932 | Oct 03, 2022, 04:42 PM |
Stephens Kristin | Chief Development Officer | Apr 01, 2022 | Option Exercise | $1.12 | 14,115 | 15,809 | 30,885 | Apr 04, 2022, 05:04 PM |
Roth David | Chief Medical Officer | Apr 01, 2022 | Option Exercise | $1.12 | 27,281 | 30,555 | 59,719 | Apr 04, 2022, 05:03 PM |
Olson Eric R | Chief Scientific Officer | Apr 01, 2022 | Option Exercise | $1.12 | 27,266 | 30,538 | 59,734 | Apr 04, 2022, 05:02 PM |
Simonian Nancy A | President & CEO | Apr 01, 2022 | Option Exercise | $1.12 | 58,883 | 65,949 | 692,723 | Apr 04, 2022, 05:02 PM |
Olson Eric R | Chief Scientific Officer | Jan 05, 2022 | Sale | $3.47 | 2,208 | 7,655 | 0 | Jan 06, 2022, 05:02 PM |
Olson Eric R | Chief Scientific Officer | Jul 01, 2021 | Sale | $5.55 | 1,164 | 6,460 | 0 | Jul 01, 2021, 05:20 PM |
Olson Eric R | Chief Scientific Officer | Mar 15, 2021 | Option Exercise | $1.01 | 3,628 | 3,664 | 3,628 | Mar 17, 2021, 05:10 PM |
Olson Eric R | Chief Scientific Officer | Mar 15, 2021 | Sale | $9.47 | 3,628 | 34,372 | 0 | Mar 17, 2021, 05:10 PM |
Young Richard A | Director | Feb 16, 2021 | Sale | $12.05 | 3,750 | 45,188 | 321,711 | Feb 18, 2021, 05:34 PM |
Young Richard A | Director | Feb 08, 2021 | Sale | $13.04 | 3,750 | 48,900 | 325,461 | Feb 10, 2021, 05:29 PM |
Young Richard A | Director | Nov 17, 2020 | Sale | $8.75 | 5,357 | 46,874 | 329,211 | Feb 10, 2021, 05:28 PM |
Young Richard A | Director | Nov 16, 2020 | Sale | $8.98 | 633 | 5,684 | 334,568 | Feb 10, 2021, 05:28 PM |
Simonian Nancy A | President & CEO | Dec 18, 2020 | Option Exercise | $6.81 | 29,917 | 203,612 | 563,606 | Dec 21, 2020, 04:58 PM |
Young Richard A | Director | Nov 17, 2020 | Sale | $8.75 | 5,357 | 46,874 | 339,211 | Nov 18, 2020, 04:33 PM |
Young Richard A | Director | Nov 16, 2020 | Sale | $8.98 | 633 | 5,684 | 344,568 | Nov 18, 2020, 04:33 PM |
Young Richard A | Director | Oct 19, 2020 | Sale | $8.75 | 5,673 | 49,639 | 335,201 | Oct 19, 2020, 06:36 PM |
Young Richard A | Director | Oct 15, 2020 | Sale | $8.75 | 317 | 2,774 | 340,874 | Oct 16, 2020, 04:39 PM |
Young Richard A | Director | Sep 15, 2020 | Sale | $10.39 | 5,990 | 62,236 | 341,191 | Sep 16, 2020, 08:32 AM |
Olson Eric R | Chief Scientific Officer | Aug 18, 2020 | Option Exercise | $1.01 | 10,787 | 10,895 | 10,787 | Aug 19, 2020, 04:35 PM |
Olson Eric R | Chief Scientific Officer | Aug 17, 2020 | Option Exercise | $1.01 | 4,963 | 5,013 | 4,963 | Aug 19, 2020, 04:35 PM |
Olson Eric R | Chief Scientific Officer | Aug 17, 2020 | Sale | $13.00 | 4,963 | 64,519 | 0 | Aug 19, 2020, 04:35 PM |
Olson Eric R | Chief Scientific Officer | Aug 18, 2020 | Sale | $13.00 | 10,787 | 140,231 | 0 | Aug 19, 2020, 04:35 PM |
Young Richard A | Director | Aug 17, 2020 | Sale | $12.59 | 5,990 | 75,414 | 347,181 | Aug 19, 2020, 04:33 PM |
AKKARAJU SRINIVAS | Director | Aug 18, 2020 | Sale | $13.10 | 158,583 | 2,076,724 | 1,274,616 | Aug 19, 2020, 04:03 PM |
AKKARAJU SRINIVAS | Director | Aug 17, 2020 | Sale | $13.00 | 744 | 9,672 | 1,433,199 | Aug 19, 2020, 04:03 PM |
Young Richard A | Director | Jul 15, 2020 | Sale | $11.85 | 5,990 | 70,982 | 353,171 | Jul 17, 2020, 04:11 PM |
Olson Eric R | Chief Scientific Officer | Jul 07, 2020 | Sale | $11.72 | 1,753 | 20,538 | 0 | Jul 07, 2020, 07:33 PM |
AKKARAJU SRINIVAS | Director | Jul 01, 2020 | Sale | $11.01 | 4,627 | 50,966 | 1,433,943 | Jul 06, 2020, 04:00 PM |
AKKARAJU SRINIVAS | Director | Jun 25, 2020 | Sale | $11.15 | 54,972 | 612,850 | 1,438,570 | Jun 25, 2020, 08:38 PM |
AKKARAJU SRINIVAS | Director | Jun 24, 2020 | Sale | $11.07 | 48,775 | 539,788 | 1,493,542 | Jun 25, 2020, 08:38 PM |
AKKARAJU SRINIVAS | Director | Jun 23, 2020 | Sale | $11.11 | 50,953 | 565,930 | 1,542,317 | Jun 25, 2020, 08:38 PM |
Young Richard A | Director | Jun 15, 2020 | Sale | $8.75 | 5,990 | 52,413 | 359,161 | Jun 16, 2020, 04:53 PM |
Young Richard A | Director | May 15, 2020 | Sale | $9.22 | 5,990 | 55,242 | 365,151 | May 15, 2020, 05:13 PM |
Alles Mark J | Director | May 13, 2020 | Buy | $8.86 | 10,000 | 88,590 | 10,000 | May 13, 2020, 05:05 PM |
Young Richard A | Director | Apr 15, 2020 | Sale | $8.75 | 23,960 | 209,650 | 371,141 | Apr 17, 2020, 04:02 PM |
Olson Eric R | Chief Scientific Officer | Feb 18, 2020 | Sale | $7.38 | 1,446 | 10,674 | 0 | Feb 20, 2020, 04:15 PM |
Simonian Nancy A | President & CEO | Dec 23, 2019 | Option Exercise | $3.04 | 52,401 | 159,299 | 533,689 | Dec 23, 2019, 04:54 PM |
Springhorn Jeremy P. | Chief Business Officer | Nov 11, 2019 | Buy | $4.99 | 9,879 | 49,328 | 24,879 | Nov 12, 2019, 04:34 PM |
Springhorn Jeremy P. | Chief Business Officer | Nov 12, 2019 | Buy | $4.97 | 10,121 | 50,268 | 35,000 | Nov 12, 2019, 04:34 PM |
Young Richard A | Director | Aug 16, 2019 | Sale | $10.00 | 22,700 | 227,000 | 395,101 | Aug 19, 2019, 04:08 PM |
Young Richard A | Director | Aug 15, 2019 | Sale | $10.00 | 2,300 | 23,000 | 417,801 | Aug 19, 2019, 04:08 PM |
ARCH Venture Fund VII, L.P. | 10% Owner | Jul 17, 2019 | Sale | $7.70 | 34,521 | 265,687 | 4,242,051 | Jul 17, 2019, 07:26 PM |
ARCH Venture Fund VII, L.P. | 10% Owner | Jul 16, 2019 | Sale | $7.81 | 25,779 | 201,277 | 4,276,572 | Jul 17, 2019, 07:26 PM |
ARCH Venture Fund VII, L.P. | 10% Owner | Jul 15, 2019 | Sale | $8.27 | 2,700 | 22,316 | 4,302,051 | Jul 17, 2019, 07:26 PM |
AKKARAJU SRINIVAS | Director | Apr 09, 2019 | Buy | $7.50 | 533,332 | 3,999,990 | 1,593,270 | Apr 11, 2019, 04:37 PM |
ARCH Venture Fund VII, L.P. | 10% Owner | Mar 14, 2019 | Sale | $8.15 | 43,000 | 350,441 | 4,305,051 | Mar 14, 2019, 06:57 PM |
ARCH Venture Fund VII, L.P. | 10% Owner | Mar 13, 2019 | Sale | $7.90 | 84,411 | 666,565 | 4,350,871 | Mar 14, 2019, 06:57 PM |
ARCH Venture Fund VII, L.P. | 10% Owner | Mar 12, 2019 | Sale | $7.37 | 40,092 | 295,374 | 4,432,462 | Mar 14, 2019, 06:57 PM |
ARCH Venture Fund VII, L.P. | 10% Owner | Mar 11, 2019 | Sale | $6.49 | 44,878 | 291,366 | 4,472,554 | Mar 11, 2019, 05:58 PM |
ARCH Venture Fund VII, L.P. | 10% Owner | Mar 08, 2019 | Sale | $6.93 | 84,496 | 585,270 | 4,517,432 | Mar 11, 2019, 05:58 PM |
ARCH Venture Fund VII, L.P. | 10% Owner | Mar 07, 2019 | Sale | $6.87 | 35,209 | 242,013 | 4,601,928 | Mar 11, 2019, 05:58 PM |
Simonian Nancy A | President & CEO | Nov 29, 2018 | Option Exercise | $1.23 | 110,588 | 136,224 | 481,288 | Dec 03, 2018, 04:06 PM |
AKKARAJU SRINIVAS | Director | Jan 31, 2018 | Buy | $9.55 | 209,424 | 1,999,999 | 1,059,938 | Feb 02, 2018, 03:53 PM |
Springhorn Jeremy P. | Chief Business Officer | Dec 15, 2017 | Buy | $9.08 | 15,000 | 136,260 | 15,000 | Dec 15, 2017, 04:02 PM |
AKKARAJU SRINIVAS | Director | Dec 14, 2017 | Buy | $8.99 | 26,600 | 239,134 | 830,494 | Dec 14, 2017, 08:22 PM |
AKKARAJU SRINIVAS | Director | Dec 13, 2017 | Buy | $8.97 | 68,400 | 613,548 | 803,894 | Dec 14, 2017, 08:22 PM |
AKKARAJU SRINIVAS | Director | Dec 12, 2017 | Buy | $9.40 | 14,774 | 138,876 | 735,494 | Dec 14, 2017, 08:22 PM |
DeSimone Colleen Elizabeth | Principal Accounting Officer | Oct 23, 2017 | Option Exercise | $3.04 | 550 | 1,672 | 550 | Oct 23, 2017, 04:44 PM |
DeSimone Colleen Elizabeth | Principal Accounting Officer | Oct 23, 2017 | Sale | $16.06 | 550 | 8,833 | 0 | Oct 23, 2017, 04:44 PM |
Young Richard A | Director | Aug 14, 2017 | Sale | $22.00 | 3,282 | 72,204 | 420,101 | Aug 16, 2017, 04:08 PM |
Olson Eric R | Chief Scientific Officer | Aug 07, 2017 | Option Exercise | $1.01 | 2,500 | 2,525 | 2,500 | Aug 08, 2017, 05:20 PM |
Olson Eric R | Chief Scientific Officer | Aug 07, 2017 | Sale | $23.59 | 2,500 | 58,969 | 0 | Aug 08, 2017, 05:20 PM |
Olson Eric R | Chief Scientific Officer | Jul 25, 2017 | Option Exercise | $1.01 | 12,500 | 12,625 | 12,500 | Jul 27, 2017, 04:09 PM |
Olson Eric R | Chief Scientific Officer | Jul 25, 2017 | Sale | $21.85 | 12,500 | 273,125 | 0 | Jul 27, 2017, 04:09 PM |
Young Richard A | Director | Jul 25, 2017 | Sale | $22.09 | 3,282 | 72,496 | 423,383 | Jul 27, 2017, 04:09 PM |
Nashat Amir | Director | Jul 06, 2016 | Buy | $12.50 | 400,000 | 5,000,000 | 1,538,333 | Jul 07, 2016, 05:41 PM |
Polaris Management Co. VII, L.L.C. | 10% Owner | Jul 06, 2016 | Buy | $12.50 | 400,000 | 5,000,000 | 1,538,333 | Jul 07, 2016, 05:41 PM |
Flagship Ventures Fund IV, L.P. | 10% Owner | Jul 06, 2016 | Buy | $12.50 | 400,000 | 5,000,000 | 3,674,660 | Jul 07, 2016, 06:04 AM |
Redmile Group, LLC | 10% Owner | Jul 06, 2016 | Buy | $12.50 | 432,746 | 5,409,325 | 366,739 | Jul 07, 2016, 06:03 AM |
Arch Venture Fund VII LP | 10% Owner | Jul 06, 2016 | Buy | $12.50 | 400,000 | 5,000,000 | 4,637,137 | Jul 07, 2016, 06:02 AM |
NELSEN ROBERT | Director | Jul 06, 2016 | Buy | $12.50 | 400,000 | 5,000,000 | 4,637,137 | Jul 06, 2016, 09:22 PM |
AISLING CAPITAL III LP | 10% Owner | Jul 06, 2016 | Buy | $12.50 | 400,000 | 5,000,000 | 908,565 | Jul 06, 2016, 05:10 PM |
Flynn James E | 10% Owner | Jul 06, 2016 | Buy | $12.50 | 120,000 | 1,500,000 | 628,566 | Jul 06, 2016, 11:54 AM |
Flynn James E | 10% Owner | Jul 06, 2016 | Buy | $12.50 | 280,000 | 3,500,000 | 1,466,654 | Jul 06, 2016, 11:54 AM |
Owner | Relationship | Date | Value($) |
AKKARAJU SRINIVAS | Director | 12/21/2023 | 3,999,998 |
Roth David | Chief Medical Officer | 12/12/2023 | 31,121 |
Roth David | Chief Medical Officer | 12/06/2023 | 24,834 |
Simonian Nancy A | President & CEO | 11/01/2023 | 29,750 |
Haas Jason | Chief Financial Officer | 11/01/2023 | 13,988 |
Roth David | Chief Medical Officer | 11/01/2023 | 13,988 |
Stephens Kristin | Chief Development Officer | 11/01/2023 | 12,601 |
Chee Conley | Chief Commercial Officer | 11/01/2023 | 13,329 |
Quirk Gerald E | Chief Legal & Compliance Offic | 10/19/2023 | 14,484 |
Roth David | Chief Medical Officer | 07/31/2023 | 29,025 |
Olson Eric R | Chief Scientific Officer | 07/17/2023 | 2,412 |
Haas Jason | Chief Financial Officer | 04/03/2023 | 1,607 |
Chee Conley | Chief Commercial Officer | 04/03/2023 | 1,698 |
Roth David | Chief Medical Officer | 04/03/2023 | 1,607 |
Stephens Kristin | Chief Development Officer | 04/03/2023 | 1,607 |
Olson Eric R | Chief Scientific Officer | 04/03/2023 | 1,607 |
Simonian Nancy A | President & CEO | 04/03/2023 | 4,778 |
TYSON TIMOTHY | Director | 09/30/2022 | 89,186 |
TYSON TIMOTHY | Director | 09/29/2022 | 16,770 |
Stephens Kristin | Chief Development Officer | 04/01/2022 | 15,809 |
Roth David | Chief Medical Officer | 04/01/2022 | 30,555 |
Olson Eric R | Chief Scientific Officer | 04/01/2022 | 30,538 |
Simonian Nancy A | President & CEO | 04/01/2022 | 65,949 |
Olson Eric R | Chief Scientific Officer | 01/05/2022 | 7,655 |
Olson Eric R | Chief Scientific Officer | 07/01/2021 | 6,460 |
Olson Eric R | Chief Scientific Officer | 03/15/2021 | 3,664 |
Olson Eric R | Chief Scientific Officer | 03/15/2021 | 34,372 |
Young Richard A | Director | 02/16/2021 | 45,188 |
Young Richard A | Director | 02/08/2021 | 48,900 |
Young Richard A | Director | 11/17/2020 | 46,874 |
Young Richard A | Director | 11/16/2020 | 5,684 |
Simonian Nancy A | President & CEO | 12/18/2020 | 203,612 |
Young Richard A | Director | 11/17/2020 | 46,874 |
Young Richard A | Director | 11/16/2020 | 5,684 |
Young Richard A | Director | 10/19/2020 | 49,639 |
Young Richard A | Director | 10/15/2020 | 2,774 |
Young Richard A | Director | 09/15/2020 | 62,236 |
Olson Eric R | Chief Scientific Officer | 08/18/2020 | 10,895 |
Olson Eric R | Chief Scientific Officer | 08/17/2020 | 5,013 |
Olson Eric R | Chief Scientific Officer | 08/17/2020 | 64,519 |
Olson Eric R | Chief Scientific Officer | 08/18/2020 | 140,231 |
Young Richard A | Director | 08/17/2020 | 75,414 |
AKKARAJU SRINIVAS | Director | 08/18/2020 | 2,076,724 |
AKKARAJU SRINIVAS | Director | 08/17/2020 | 9,672 |
Young Richard A | Director | 07/15/2020 | 70,982 |
Olson Eric R | Chief Scientific Officer | 07/07/2020 | 20,538 |
AKKARAJU SRINIVAS | Director | 07/01/2020 | 50,966 |
AKKARAJU SRINIVAS | Director | 06/25/2020 | 612,850 |
AKKARAJU SRINIVAS | Director | 06/24/2020 | 539,788 |
AKKARAJU SRINIVAS | Director | 06/23/2020 | 565,930 |
Young Richard A | Director | 06/15/2020 | 52,413 |
Young Richard A | Director | 05/15/2020 | 55,242 |
Alles Mark J | Director | 05/13/2020 | 88,590 |
Young Richard A | Director | 04/15/2020 | 209,650 |
Olson Eric R | Chief Scientific Officer | 02/18/2020 | 10,674 |
Simonian Nancy A | President & CEO | 12/23/2019 | 159,299 |
Springhorn Jeremy P. | Chief Business Officer | 11/11/2019 | 49,328 |
Springhorn Jeremy P. | Chief Business Officer | 11/12/2019 | 50,268 |
Young Richard A | Director | 08/16/2019 | 227,000 |
Young Richard A | Director | 08/15/2019 | 23,000 |
ARCH Venture Fund VII, L.P. | 10% Owner | 07/17/2019 | 265,687 |
ARCH Venture Fund VII, L.P. | 10% Owner | 07/16/2019 | 201,277 |
ARCH Venture Fund VII, L.P. | 10% Owner | 07/15/2019 | 22,316 |
AKKARAJU SRINIVAS | Director | 04/09/2019 | 3,999,990 |
ARCH Venture Fund VII, L.P. | 10% Owner | 03/14/2019 | 350,441 |
ARCH Venture Fund VII, L.P. | 10% Owner | 03/13/2019 | 666,565 |
ARCH Venture Fund VII, L.P. | 10% Owner | 03/12/2019 | 295,374 |
ARCH Venture Fund VII, L.P. | 10% Owner | 03/11/2019 | 291,366 |
ARCH Venture Fund VII, L.P. | 10% Owner | 03/08/2019 | 585,270 |
ARCH Venture Fund VII, L.P. | 10% Owner | 03/07/2019 | 242,013 |
Simonian Nancy A | President & CEO | 11/29/2018 | 136,224 |
AKKARAJU SRINIVAS | Director | 01/31/2018 | 1,999,999 |
Springhorn Jeremy P. | Chief Business Officer | 12/15/2017 | 136,260 |
AKKARAJU SRINIVAS | Director | 12/14/2017 | 239,134 |
AKKARAJU SRINIVAS | Director | 12/13/2017 | 613,548 |
AKKARAJU SRINIVAS | Director | 12/12/2017 | 138,876 |
DeSimone Colleen Elizabeth | Principal Accounting Officer | 10/23/2017 | 1,672 |
DeSimone Colleen Elizabeth | Principal Accounting Officer | 10/23/2017 | 8,833 |
Young Richard A | Director | 08/14/2017 | 72,204 |
Olson Eric R | Chief Scientific Officer | 08/07/2017 | 2,525 |
Olson Eric R | Chief Scientific Officer | 08/07/2017 | 58,969 |
Olson Eric R | Chief Scientific Officer | 07/25/2017 | 12,625 |
Olson Eric R | Chief Scientific Officer | 07/25/2017 | 273,125 |
Young Richard A | Director | 07/25/2017 | 72,496 |
Nashat Amir | Director | 07/06/2016 | 5,000,000 |
Polaris Management Co. VII, L.L.C. | 10% Owner | 07/06/2016 | 5,000,000 |
Flagship Ventures Fund IV, L.P. | 10% Owner | 07/06/2016 | 5,000,000 |
Redmile Group, LLC | 10% Owner | 07/06/2016 | 5,409,325 |
Arch Venture Fund VII LP | 10% Owner | 07/06/2016 | 5,000,000 |
NELSEN ROBERT | Director | 07/06/2016 | 5,000,000 |
AISLING CAPITAL III LP | 10% Owner | 07/06/2016 | 5,000,000 |
Flynn James E | 10% Owner | 07/06/2016 | 1,500,000 |
Flynn James E | 10% Owner | 07/06/2016 | 3,500,000 |
Fund | # Shares Owned | % of Portfolio | % Change | Investing Style |
---|---|---|---|---|
ADAGE CAPITAL PARTNERS GP, L.L.C. | 2,071,914 | 0.03% | 187% | Other |
BLACKROCK INC. | 246,944 | 0.00005% | 0.49% | Other |
GEODE CAPITAL MANAGEMENT, LLC | 161,563 | 0.00013% | 17.19% | Other |
UBS OCONNOR LLC | 130,000 | 0.07% | New | Value |
RENAISSANCE TECHNOLOGIES LLC | 58,635 | 0.00071% | 19.09% | Other |
Period of Report: 12/31/2023
10-K/10-Q Filings: View